APA (7th ed.) Citation

Catapano, A., Shlyakhto, E. V., Martynov, A. I., Oganov, R. G., Kukharchuk, V. V., Shestakova, M. V., . . . Koziolova, O. N. EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE. «SILICEA-POLIGRAF» LLC.

Chicago Style (17th ed.) Citation

Catapano, A., et al. EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE. «SILICEA-POLIGRAF» LLC.

MLA (9th ed.) Citation

Catapano, A., et al. EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE. «SILICEA-POLIGRAF» LLC.